Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data

Current Pharmaceutical Design
Karina ClaassenStefan Willmann

Abstract

Among pediatric patients, preterm neonates and newborns are the most vulnerable subpopulation. Rapid developmental changes of physiological factors affecting the pharmacokinetics of drug substances in newborns require extreme care in dose and dose regimen decisions. These decisions could be supported by in silico methods such as physiologically-based pharmacokinetic (PBPK) modeling. In a comprehensive literature search, the physiological information of preterm neonates that is required to establish a PBPK model has been summarized and implemented into the database of a generic PBPK software. Physiological parameters include the organ weights and blood flow rates, tissue composition, as well as ontogeny information about metabolic and elimination processes in the liver and kidney. The aim of this work is to evaluate the model's accuracy in predicting the pharmacokinetics following intravenous administration of two model drugs with distinct physicochemical properties and elimination pathways based on earlier reported in vivo data. To this end, PBPK models of amikacin and paracetamol have been set up to predict their plasma levels in preterm neonates. Predicted plasma concentration-time profiles were compared to experimentally obt...Continue Reading

Citations

Jan 25, 2018·Expert Opinion on Drug Metabolism & Toxicology·Tamara Van DongeKarel Allegaert
May 30, 2020·The Journal of International Medical Research·Yan YueDezhi Mu
Dec 3, 2017·International Journal of Legal Medicine·Nadine SchaeferFrank Ramsthaler
Mar 24, 2018·CPT: Pharmacometrics & Systems Pharmacology·André DallmannThomas Eissing
Sep 15, 2016·Expert Opinion on Drug Metabolism & Toxicology·Anne SmitsKarel Allegaert
Jan 11, 2016·Paediatric Drugs·Joseph B Cantey
Dec 18, 2018·Expert Opinion on Drug Metabolism & Toxicology·Anne SmitsKarel Allegaert
Feb 3, 2019·British Journal of Clinical Pharmacology·Kevin M WattUNKNOWN Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee
Apr 11, 2018·Clinical Pharmacology and Therapeutics·André DallmannThomas Eissing
Aug 17, 2018·Journal of Clinical Pharmacology·André DallmannGilbert Koch
Sep 11, 2019·Journal of Clinical Pharmacology·Ibrahim InceStefan Willmann
Oct 5, 2019·Clinical Pharmacokinetics·Khaled AbduljalilTrevor N Johnson
Sep 19, 2020·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Tamara van DongeMarc Pfister
Jul 22, 2020·Clinical Pharmacology and Therapeutics·Sara N SalernoUNKNOWN Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee
Feb 1, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yu-Mei TanJeffrey W Fisher
Jun 23, 2021·Clinical Pharmacokinetics·Samit GangulyUNKNOWN Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.